-
Boc-D-FMK: Linking Apoptosis to Drug Metabolism
2026-09-09
Boc-D-FMK is a cell-permeable pan-caspase inhibitor for separating caspase-dependent cell death from transcriptional changes in drug metabolism. This article develops a decision framework connecting apoptosis research with the ATF5–CYP2B6 findings reported in glioblastoma cells.
-
Cinoxacin: In Vitro Activity and Resistance
2026-09-09
The 1975 study by Lumish and Norden established Cinoxacin as a synthetic quinolone antibiotic with useful in vitro activity against many aerobic gram-negative bacilli, especially Escherichia coli. Its principal contributions were a systematic MIC survey, validation of disk diffusion against agar dilution, demonstration of bactericidal activity, and an early warning that resistance could emerge during serial drug exposure.
-
Z-VEID-FMK in Host–Virus Caspase-6 Assays
2026-09-08
Z-VEID-FMK is a cell-permeable caspase-6 inhibitor for testing whether protease activity drives apoptosis or viral immune evasion. This article develops an assay strategy around PRRSV N-protein cleavage, linking catalytic inhibition to IRF3, interferon, and replication readouts.
-
Gamithromycin PK/PD in Bovine Respiratory Disease
2026-09-07
This prospective clinical study linked gamithromycin exposure in plasma and pulmonary epithelial lining fluid (PELF) with treatment outcomes in naturally occurring bovine respiratory disease. Its key contribution was an individual-level PK/PD framework showing that higher exposure relative to pathogen MIC, particularly PELF AUC0–24/MIC for Pasteurella multocida, was associated with treatment success.
-
Fumagillin Against Azumiobodo hoyamushi
2026-09-07
Park and colleagues compared 20 compounds against Azumiobodo hoyamushi, identifying fumagillin as a moderately active agent in vitro rather than a leading disinfectant candidate. The study’s main contribution was to combine a broad parasite screen with validation in experimentally infected ascidians, while showing that formalin and chlorine dioxide produced the clearest reduction in parasite burden under the tested conditions.
-
I-BET151 (GSK1210151A): Practical Lab Guide
2026-09-05
I-BET151 (GSK1210151A), SKU B1500, is a selective BET bromodomain inhibitor for controlled BRD2, BRD3, and BRD4 perturbation in preclinical cancer biology workflows. This guide covers stock preparation, assay controls, apoptosis and cell-cycle readouts, and limitations when no directly matched paper protocol is available; the compound is for research use only, not diagnostic or therapeutic use.
-
Pemetrexed: From Folate Stress to Repair Strategy
2026-09-04
Pemetrexed is more than a multi-target antifolate: it is a translational probe for connecting nucleotide stress with DNA-repair state. This article outlines how to use pemetrexed disodium in cancer chemotherapy research, with malignant mesothelioma and non-small cell lung carcinoma models as strategic test systems.
-
Isoproterenol Sulfate Dihydrate in SAN Research
2026-09-04
Isoproterenol sulfate dihydrate is a non-selective β-adrenergic agonist for controlled studies of beta-adrenergic receptor signaling, cAMP/PKA pathway responses, and cardiovascular research. In human SAN-plexus assembloids, it can serve as an acute functional challenge, but agonist responsiveness alone does not establish pacemaker maturation or neuron-to-pacemaker mechanism.
-
SB743921: KSP Inhibitor Workflow for Cancer Research
2026-09-04
SB743921 enables selective KSP inhibition while helping researchers distinguish mitotic arrest from irreversible cell death. This workflow combines dose-response profiling, time-resolved viability measurements, and orthogonal apoptosis assays for more informative cancer research data.
-
Losartan: AT1 Blockade for Vascular Research
2026-09-03
Losartan is an angiotensin II receptor antagonist used to study AT1 receptor signaling, vascular tone, and hypertension research. Supplier-reported data support its use as a selective AT1 research tool, while recent evidence suggests that ARB-class signaling can also remodel collagen-rich tumor microenvironments.
-
GPX Signaling and Axonal Fusion After Nerve Injury
2026-09-02
The reference study identifies lipid peroxidation and ferroptosis signaling as dose-sensitive regulators of regenerative axonal fusion. Using genetic and pharmacological models in Caenorhabditis elegans and mice, it connects GPX inhibition to phosphatidylserine exposure, PSR-1 condensation, EFF-1-dependent fusion, and improved recovery after sciatic nerve injury.
-
Neomycin sulfate Workflows for RNA and Channel Studies
2026-09-02
Neomycin sulfate is an aminoglycoside antibiotic that functions as a mechanistic probe for structured RNA, DNA triplexes, and ryanodine receptor channels. This guide connects practical assay design with a recent allergic-rhinitis study, while clearly separating validated findings from workflow recommendations.
-
10074-G5 in the miR-196a–MYC Axis
2026-09-01
Explore how the c-Myc inhibitor 10074-G5 can interrogate the miR-196a/TERT/NFκB axis in esophageal adenocarcinoma. This mechanistic perspective connects c-Myc/Max disruption with smarter apoptosis, cell-cycle, EMT, and translational assay decisions.
-
YTHDF1 Phase Separation in SSC Fate Transition
2026-09-01
The reference study shows that YTHDF1 liquid-liquid phase separation (LLPS) promotes direct conversion of spermatogonial stem cells into neural stem cell-like cells by activating the IκB–NF-κB–CCND1 axis. Its perturbation and rescue experiments connect m6A-dependent RNA translation control with a defined cell-fate transition, offering a mechanistic framework for studying protein–RNA condensates in stem-cell biology.
-
BHPF Inhibition of GPER in Neuroblastoma Cells
2026-08-31
A 2024 Environmental Science & Technology study identifies fluorene-9-bisphenol as a potential GPER inhibitor and links its activity to direct receptor binding at Trp2726.48 and Glu2756.51. By combining molecular dynamics, mutagenesis, receptor knockout, calcium signaling, and cytotoxicity assays, the work provides a mechanistic framework for evaluating endocrine-disrupting effects of BPA substitutes in neural cells.